These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 30036789)

  • 1. Loss of integrity of doxorubicin liposomes during transcellular transportation evidenced by fluorescence resonance energy transfer effect.
    Li D; Zhuang J; Yang Y; Wang D; Yang J; He H; Fan W; Banerjee A; Lu Y; Wu W; Gan L; Qi J
    Colloids Surf B Biointerfaces; 2018 Nov; 171():224-232. PubMed ID: 30036789
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lipid nanocapsules maintain full integrity after crossing a human intestinal epithelium model.
    Roger E; Gimel JC; Bensley C; Klymchenko AS; Benoit JP
    J Control Release; 2017 May; 253():11-18. PubMed ID: 28274740
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Click modification of multifunctional liposomes bearing hyperbranched polyether chains.
    Fritz T; Hirsch M; Richter FC; Müller SS; Hofmann AM; Rusitzka KA; Markl J; Massing U; Frey H; Helm M
    Biomacromolecules; 2014 Jul; 15(7):2440-8. PubMed ID: 24805163
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Insight into the in vivo translocation of oral liposomes by fluorescence resonance energy transfer effect.
    Liu W; Li D; Dong Z; Liu K; He H; Lu Y; Wu W; Li Q; Gan L; Qi J
    Int J Pharm; 2020 Sep; 587():119682. PubMed ID: 32717284
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tracking Drugs and Lipids: Quantitative Mass Spectrometry Imaging of Liposomal Doxorubicin Delivery and Bilayer Fate in Three-Dimensional Tumor Models.
    Lopez A; Holbrook JH; Kemper GE; Lukowski JK; Andrews WT; Hummon AB
    Anal Chem; 2024 Jun; 96(22):9254-9261. PubMed ID: 38778440
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanism of hepatic targeting via oral administration of DSPE-PEG-cholic acid-modified nanoliposomes.
    Li Y; Zhu C
    Int J Nanomedicine; 2017; 12():1673-1684. PubMed ID: 28280334
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Doxorubicin-loaded liposomes: enhancing the oral bioavailability by modulation of physicochemical characteristics.
    Daeihamed M; Haeri A; Ostad SN; Akhlaghi MF; Dadashzadeh S
    Nanomedicine (Lond); 2017 May; 12(10):1187-1202. PubMed ID: 28447868
    [TBL] [Abstract][Full Text] [Related]  

  • 8. C8-glycosphingolipids preferentially insert into tumor cell membranes and promote chemotherapeutic drug uptake.
    Cordeiro Pedrosa LR; van Cappellen WA; Steurer B; Ciceri D; ten Hagen TL; Eggermont AM; Verheij M; Goñi FM; Koning GA; Contreras FX
    Biochim Biophys Acta; 2015 Aug; 1848(8):1656-70. PubMed ID: 25917957
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hydration of surfactant-modified and PEGylated cationic cholesterol-based liposomes and corresponding lipoplexes by monitoring a fluorescent probe and the dielectric relaxation time.
    Maitani Y; Nakamura A; Tanaka T; Aso Y
    Int J Pharm; 2012 May; 427(2):372-8. PubMed ID: 22348874
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Doxorubicin liposomes as an investigative model to study the skin permeation of nanocarriers.
    Boakye CH; Patel K; Singh M
    Int J Pharm; 2015 Jul; 489(1-2):106-16. PubMed ID: 25910414
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Liposomal doxorubicin doubly functionalized with CCK8 and R8 peptide sequences for selective intracellular drug delivery.
    Ringhieri P; Diaferia C; Galdiero S; Palumbo R; Morelli G; Accardo A
    J Pept Sci; 2015 May; 21(5):415-25. PubMed ID: 25754969
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vascular targeting of doxorubicin using cationic liposomes.
    Wu J; Lee A; Lu Y; Lee RJ
    Int J Pharm; 2007 Jun; 337(1-2):329-35. PubMed ID: 17275230
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of lipid composition on the properties of doxorubicin-loaded liposomes.
    Sakai-Kato K; Nanjo K; Kawanishi T; Okuda H; Goda Y
    Ther Deliv; 2015 Jul; 6(7):785-94. PubMed ID: 26228772
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Non-Covalent Assembly Method that Simultaneously Endows a Liposome Surface with Targeting Ligands, Protective PEG Chains, and Deep-Red Fluorescence Reporter Groups.
    Shaw SK; Liu W; Brennan SP; de Lourdes Betancourt-Mendiola M; Smith BD
    Chemistry; 2017 Sep; 23(51):12646-12654. PubMed ID: 28736857
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In Vivo Biomolecule Corona around Blood-Circulating, Clinically Used and Antibody-Targeted Lipid Bilayer Nanoscale Vesicles.
    Hadjidemetriou M; Al-Ahmady Z; Mazza M; Collins RF; Dawson K; Kostarelos K
    ACS Nano; 2015 Aug; 9(8):8142-56. PubMed ID: 26135229
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polyethylene glycol-complexed cationic liposome for enhanced cellular uptake and anticancer activity.
    Jung SH; Jung SH; Seong H; Cho SH; Jeong KS; Shin BC
    Int J Pharm; 2009 Dec; 382(1-2):254-61. PubMed ID: 19666094
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of surface charge, particle size, and modification by polyethylene glycol of liposomes on their association with Caco-2 cells across an unstirred water layer.
    Kono Y; Iwasaki A; Fujita T
    Pharmazie; 2018 Jan; 73(1):3-8. PubMed ID: 29441943
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative study of dye-loaded liposome accumulation in sensitive and resistant human breast cancer cells.
    Yefimova SL; Kurilchenko IY; Tkacheva TN; Rozhkov VA; Sorokin AV; Lukianova NY; Bezdenezhnykh NA; Malyukin YV; Chekhun VF
    Exp Oncol; 2012 Jul; 34(2):101-6. PubMed ID: 23013761
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drug release rate influences the pharmacokinetics, biodistribution, therapeutic activity, and toxicity of pegylated liposomal doxorubicin formulations in murine breast cancer.
    Charrois GJ; Allen TM
    Biochim Biophys Acta; 2004 May; 1663(1-2):167-77. PubMed ID: 15157619
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of membrane properties on uptake and transcytosis of colloidal nanocarriers across an epithelial cell barrier model.
    Orthmann A; Zeisig R; Koklic T; Sentjurc M; Wiesner B; Lemm M; Fichtner I
    J Pharm Sci; 2010 May; 99(5):2423-33. PubMed ID: 20014431
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.